Technology News and Research

RSS

GW School of Nursing receives full accreditation from CCNE

The George Washington University School of Nursing has received full accreditation for its bachelor's, master's and doctoral programs from the Commission on Collegiate Nursing Education (CCNE).

2 Nov 2010

Stroke Teams enroll first patient in clinical trial of Penumbra System with Pulse flow restoration device

The Stroke Teams at the University Hospital Dresden in Dresden, Germany, and the University Hospital Göttingen in Göttingen, Germany, have enrolled the first patients in an international clinical trial to assess the safety and effectiveness of aspiration with the Penumbra System in conjunction with the Pulse flow restoration device.

2 Nov 2010

Eli Lilly's new research center to focus on diabetes in China

Eli Lilly and Company announced today plans to open a research center focused on diabetes in China, where the incidence of the disease has reached epidemic proportions.

2 Nov 2010

GSN closes $12M Series C financing

Gene Security Network, Inc. today announced the closing of its $12M Series C financing. The financing round was led by Sequoia Capital and included Claremont Creek Ventures, Founders Fund, and Lightspeed Venture Partners.

2 Nov 2010

Research on AID enzyme could improve therapy for lymphoma, leukemia

A recent scientific discovery made by researchers at the Institut de recherches cliniques de Montr-al (IRCM) led by Dr. Javier Marcelo Di Noia, Director of the Mechanisms and Genetic Diversity research unit, was published online today by The Journal of Experimental Medicine. The team identified a mechanism regulating activation-induced deaminase (AID), which could be important for the therapy of some types of lymphoma and leukemia.

2 Nov 2010

BioCancell's Phase I/IIa clinical trial of BC-819 shows positive result for pancreatic cancer

BioCancell, a developer of anti-cancer drugs, announced success in attaining the goals of its Phase I/IIa clinical trial of BC-819 as a treatment for pancreatic cancer, which demonstrated an excellent safety profile and preliminary efficacy.

2 Nov 2010

Arrayit sells third advanced microarray manufacturing system to UT Southwestern

Arrayit Corporation announced today that it has sold a third advanced microarray manufacturing system to the University of Texas Southwestern Medical Center at Dallas. The NanoPrint LM60 Microarrayer equipped with Arrayit's Patented Microarray Manufacturing Technology (US Patent 6,101,946) is a computer-driven robotic microarray manufacturing system that enables the screening of 1.5 million lead therapeutic compounds per run, and the NanoPrint LM210 enables more than 5 million.

2 Nov 2010

Novel technology using quantum dots increases drug uptake in lung injury

Researchers at the University at Buffalo have developed a novel technology using quantum dots that is expected to have major implications for research and treatment of tuberculosis, as well as other inflammatory lung diseases.

2 Nov 2010

Zynx Health's clinical support solution receives US patent

Zynx Health, the market leader in providing evidence-based and experience-based clinical decision support solutions, today announced that the United States Patent and Trademark Office (USPTO) has issued United States Patent 7,822,626 covering their extensive suite of tools that facilitate and enhance the capability within a healthcare institution to establish and maintain an evidence-based best practice approach to providing patient care.

2 Nov 2010

Rubicon's PicoPlex kits provide DNA methylation profiling using next-generation sequencing

Rubicon Genomics today reported data demonstrating that its PicoPlex kits currently marketed for the analysis of single cells for research and diagnostic applications also provide important advantages for genetic and epigenetic profiling using next-generation sequencing (NGS).

2 Nov 2010

X-BODY receives research grant for therapeutic project against metastatic tumor stem cells

X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.

2 Nov 2010

PharmaTrust signs agreement with Sagamok community to provide MedCentre

PharmaTrust has signed the first agreement of its kind to provide a MedCentre to a First Nation community in northern Ontario. In a signing ceremony on October 29th the Sagamok Anishnawbek First Nation community finalized an agreement with PharmaTrust for the deployment of a MedCentre, which will give the community the option of convenient 24/7 access to pharmacy services.

2 Nov 2010

National Jewish Health's chronic urticaria diagnostic assay receives US patent

National Jewish Health has received a US patent for a method of detecting autoimmune chronic urticaria, which will help assure many patients that dramatic changes in lifestyle are not needed to treat the condition.

2 Nov 2010

454 Life Sciences and DNA Electronics partner to develop high-throughput DNA sequencing system

454 Life Sciences, a Roche Company, announced today that it has entered an exclusive partnership with DNA Electronics for the development of a low-cost, high-throughput DNA sequencing system. As part of the agreement, Roche has signed a non-exclusive license for relevant IP from DNA Electronics' proprietary semiconductor technology portfolio, which enables sensitive detection of nucleotide incorporation during sequencing.

1 Nov 2010

Today's OpEds: Health law and private insurance; Corporate wellness programs; Geriatric mental health

Once again, average health insurance rates are expected to rise by double digits next yearas they have every year since 2002. ... Given that Obama would veto a repeal, we hope the next Congress instead begins the hard work of re-crafting the new law with a goal of breaking the annual spikes in cost (The Denver Post, 11/1).

1 Nov 2010

Calypso Medical to showcase FDA cleared Dynamic Edge Gating Technology at 52nd ASTRO

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced it will showcase Dynamic Edge™ Gating Technology, recently cleared by the U.S. Food and Drug Administration, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO), now underway at the San Diego Convention Center.

1 Nov 2010

BSD MTX-180 MicroThermX Microwave Ablation System receives CE Mark approval

BSD Medical Corporation, the company that pioneered heat therapy applications, today reported that the Company has received CE Mark approval for the commercial sale of The MicroThermX Microwave Ablation System (MTX-180) in Europe. CE marking approval allows BSD to market the MTX-180 in the 30 countries that comprise the European Union (EU) and the European Free Trade Association (EFTA).

1 Nov 2010

International Isotopes completes private placement

International Isotopes Inc. announces completion of a private placement on October 29, 2010 that will immediately provide the company with approximately $5.8 million in cash to continue its efforts on the licensing and design of its planned environmentally friendly, green technology uranium de-conversion and fluorine extraction processing facility.

1 Nov 2010

GlycosBio, Malaysian Bio-XCell enter agreement to build biochemical plant and biotechnology R&D facility

Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations for the production of sustainable biochemicals, today exchanged definitive agreements with Malaysian Bio-XCell for the establishment of the Company's industrial biochemical plant and biotechnology R&D facility in Malaysia

1 Nov 2010

Kaplan EduNeering opens new office in Hong Kong

Kaplan EduNeering, a leading provider of compliance and knowledge management solutions, announces today the opening of a Hong Kong office to serve clients based in Asia. The new location, which will house sales and support staff, is based in the Hong Kong offices of its parent company, Kaplan, Inc. In 2008, Kaplan EduNeering opened a European-based location in Reading, England.

1 Nov 2010

Technology News and Research

GW School of Nursing receives full accreditation from CCNE

Stroke Teams enroll first patient in clinical trial of Penumbra System with Pulse flow restoration device

Eli Lilly's new research center to focus on diabetes in China

GSN closes $12M Series C financing

Research on AID enzyme could improve therapy for lymphoma, leukemia

BioCancell's Phase I/IIa clinical trial of BC-819 shows positive result for pancreatic cancer

Arrayit sells third advanced microarray manufacturing system to UT Southwestern

Novel technology using quantum dots increases drug uptake in lung injury

Zynx Health's clinical support solution receives US patent

Rubicon's PicoPlex kits provide DNA methylation profiling using next-generation sequencing

X-BODY receives research grant for therapeutic project against metastatic tumor stem cells

PharmaTrust signs agreement with Sagamok community to provide MedCentre

National Jewish Health's chronic urticaria diagnostic assay receives US patent

454 Life Sciences and DNA Electronics partner to develop high-throughput DNA sequencing system

Today's OpEds: Health law and private insurance; Corporate wellness programs; Geriatric mental health

Calypso Medical to showcase FDA cleared Dynamic Edge Gating Technology at 52nd ASTRO

BSD MTX-180 MicroThermX Microwave Ablation System receives CE Mark approval

International Isotopes completes private placement

GlycosBio, Malaysian Bio-XCell enter agreement to build biochemical plant and biotechnology R&D facility

Kaplan EduNeering opens new office in Hong Kong

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News